MCC and companion animals: Ann Reportreading the annual report received today - p. 5:
"One such product (="exciting products" in development) is a vaccine for horses aganist Rhodococcus equi, a chronic and often fata cause of bronchopneumonia in foals...."
"The Company is also investigating the use of MCC technology for cancer therapy in companion animals. Studies using canine cancer patients are the most effective means of demonstrationg the efficacy of this technology as a therapeutic option. (...) The Conmpany bel;ieves there are significant markets uin North America, Europe and Japan that will be receptive to this therapy...."
FINALLY, THEY ARE WORKING ON THIS !!!
HUGE MARKET